NATR Quote, Financials, Valuation and Earnings

Bridgford Foods Corp. has a net margin of 3.65% compared to Nature's Sunshine Products, Inc.'s net margin of -1.52%. Nature's Sunshine Products, Inc.'s return on equity of 12.47% beat Bridgford Foods Corp.'s return on equity of -10.87%.

Nature's Sunshine Products, Inc. has a consensus price target of $33.00, signalling upside risk potential of 33.28%. On the other hand Bridgford Foods Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nature's Sunshine Products, Inc. has higher upside potential than Bridgford Foods Corp., analysts believe Nature's Sunshine Products, Inc. is more attractive than Bridgford Foods Corp..

Nature's Sunshine Products, Inc. has a beta of 0.937, which suggesting that the stock is 6.306% less volatile than S&P 500. In comparison Bridgford Foods Corp. has a beta of -0.248, suggesting its less volatile than the S&P 500 by 124.817%.

Nature's Sunshine Products, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bridgford Foods Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nature's Sunshine Products, Inc. pays -- of its earnings as a dividend. Bridgford Foods Corp. pays out -- of its earnings as a dividend.

Nature's Sunshine Products, Inc. quarterly revenues are $123.8M, which are larger than Bridgford Foods Corp. quarterly revenues of $55.3M. Nature's Sunshine Products, Inc.'s net income of $4.5M is higher than Bridgford Foods Corp.'s net income of -$843K. Notably, Nature's Sunshine Products, Inc.'s price-to-earnings ratio is 23.40x while Bridgford Foods Corp.'s PE ratio is 62.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nature's Sunshine Products, Inc. is 0.95x versus 0.29x for Bridgford Foods Corp.. Usually stocks with elevated PS ratios are considered overvalued.

RegalWorks Media, Inc. has a net margin of 3.65% compared to Nature's Sunshine Products, Inc.'s net margin of -821.05%. Nature's Sunshine Products, Inc.'s return on equity of 12.47% beat RegalWorks Media, Inc.'s return on equity of -7.77%.

Nature's Sunshine Products, Inc. has a consensus price target of $33.00, signalling upside risk potential of 33.28%. On the other hand RegalWorks Media, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nature's Sunshine Products, Inc. has higher upside potential than RegalWorks Media, Inc., analysts believe Nature's Sunshine Products, Inc. is more attractive than RegalWorks Media, Inc..

Nature's Sunshine Products, Inc. has a beta of 0.937, which suggesting that the stock is 6.306% less volatile than S&P 500. In comparison RegalWorks Media, Inc. has a beta of -1.039, suggesting its less volatile than the S&P 500 by 203.853%.

Nature's Sunshine Products, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. RegalWorks Media, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nature's Sunshine Products, Inc. pays -- of its earnings as a dividend. RegalWorks Media, Inc. pays out -- of its earnings as a dividend.

Nature's Sunshine Products, Inc. quarterly revenues are $123.8M, which are larger than RegalWorks Media, Inc. quarterly revenues of $1.9K. Nature's Sunshine Products, Inc.'s net income of $4.5M is higher than RegalWorks Media, Inc.'s net income of -$15.6K. Notably, Nature's Sunshine Products, Inc.'s price-to-earnings ratio is 23.40x while RegalWorks Media, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nature's Sunshine Products, Inc. is 0.95x versus 1,028.64x for RegalWorks Media, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spectrum Brands Holdings, Inc. has a net margin of 3.65% compared to Nature's Sunshine Products, Inc.'s net margin of 4.34%. Nature's Sunshine Products, Inc.'s return on equity of 12.47% beat Spectrum Brands Holdings, Inc.'s return on equity of 5.46%.

Nature's Sunshine Products, Inc. has a consensus price target of $33.00, signalling upside risk potential of 33.28%. On the other hand Spectrum Brands Holdings, Inc. has an analysts' consensus of $85.29 which suggests that it could grow by 10.93%. Given that Nature's Sunshine Products, Inc. has higher upside potential than Spectrum Brands Holdings, Inc., analysts believe Nature's Sunshine Products, Inc. is more attractive than Spectrum Brands Holdings, Inc..

Nature's Sunshine Products, Inc. has a beta of 0.937, which suggesting that the stock is 6.306% less volatile than S&P 500. In comparison Spectrum Brands Holdings, Inc. has a beta of 0.639, suggesting its less volatile than the S&P 500 by 36.137%.

Nature's Sunshine Products, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spectrum Brands Holdings, Inc. offers a yield of 2.45% to investors and pays a quarterly dividend of $0.47 per share. Nature's Sunshine Products, Inc. pays -- of its earnings as a dividend. Spectrum Brands Holdings, Inc. pays out 48.84% of its earnings as a dividend. Spectrum Brands Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Nature's Sunshine Products, Inc. quarterly revenues are $123.8M, which are smaller than Spectrum Brands Holdings, Inc. quarterly revenues of $677M. Nature's Sunshine Products, Inc.'s net income of $4.5M is lower than Spectrum Brands Holdings, Inc.'s net income of $29.4M. Notably, Nature's Sunshine Products, Inc.'s price-to-earnings ratio is 23.40x while Spectrum Brands Holdings, Inc.'s PE ratio is 18.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nature's Sunshine Products, Inc. is 0.95x versus 0.68x for Spectrum Brands Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

USANA Health Sciences, Inc. has a net margin of 3.65% compared to Nature's Sunshine Products, Inc.'s net margin of -0.71%. Nature's Sunshine Products, Inc.'s return on equity of 12.47% beat USANA Health Sciences, Inc.'s return on equity of 1.96%.

Nature's Sunshine Products, Inc. has a consensus price target of $33.00, signalling upside risk potential of 33.28%. On the other hand USANA Health Sciences, Inc. has an analysts' consensus of $39.00 which suggests that it could grow by 121.47%. Given that USANA Health Sciences, Inc. has higher upside potential than Nature's Sunshine Products, Inc., analysts believe USANA Health Sciences, Inc. is more attractive than Nature's Sunshine Products, Inc..

Nature's Sunshine Products, Inc. has a beta of 0.937, which suggesting that the stock is 6.306% less volatile than S&P 500. In comparison USANA Health Sciences, Inc. has a beta of 0.642, suggesting its less volatile than the S&P 500 by 35.795%.

Nature's Sunshine Products, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. USANA Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nature's Sunshine Products, Inc. pays -- of its earnings as a dividend. USANA Health Sciences, Inc. pays out -- of its earnings as a dividend.

Nature's Sunshine Products, Inc. quarterly revenues are $123.8M, which are smaller than USANA Health Sciences, Inc. quarterly revenues of $226.2M. Nature's Sunshine Products, Inc.'s net income of $4.5M is higher than USANA Health Sciences, Inc.'s net income of -$1.6M. Notably, Nature's Sunshine Products, Inc.'s price-to-earnings ratio is 23.40x while USANA Health Sciences, Inc.'s PE ratio is 31.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nature's Sunshine Products, Inc. is 0.95x versus 0.35x for USANA Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.